Stay updated on Immunotherapy Combos with BMS-986179 in Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combos with BMS-986179 in Clinical Trial page.

Latest updates to the Immunotherapy Combos with BMS-986179 in Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 updated (replacing v3.4.2).SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 appears to be a minor site update with no visible changes to the study details, enrollment, or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; appears to be an internal update with no user-facing changes.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now includes a glossary toggle, updates capitalization on QC-related labels and FEAR Act references, and bumps the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page header now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedThe study Locations section was updated to add sites in Illinois, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas, New South Wales, Victoria, Ontario, and Quebec, and to remove prior location entries; the revision note indicates a change from v3.3.2 to v3.3.3.SummaryDifference1%

Stay in the know with updates to Immunotherapy Combos with BMS-986179 in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combos with BMS-986179 in Clinical Trial page.